

(Sharecast News) - Respiratory drug discovery and development company Synairgen announced on Monday that dosing has started in the inhaled interferon ...


IN BRIEF: Synairgen Begins Dosing Of Covid Patients In SNG001 Sub-Study


TRADING UPDATES: Intuitive Plots GBP250,000 Investment In Microsaic


IN BRIEF: Synairgen Recruits Covid-19 Patients Into Phase II Trial


Synairgen Doses First Patient In Covid-19 Treatment Trial


By Nancy LapidJan 11 (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find tr...


LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound


Synairgen Gets Fast Track Designation From US FDA For Covid-19 Vaccine